Graeser M, Gluz O, Biehl C, Ulbrich-Gebauer D, et al. Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial. Clin Cancer Res 2023;29:805-814.
PMID: 36441798